Live tape
Top 8, mentions 7d11,159TSLA2,318 mentions▲ +0.05SPCX1,636 mentions▲ +0.07GOOGL1,570 mentions▲ +0.04CRWV1,436 mentions▲ +0.03NVDA1,214 mentions▲ +0.07QQQ1,179 mentions▲ +0.05NBIS931 mentions▲ +0.06META875 mentions▲ +0.05

Equity · Healthcare

VRTX

NASDAQ

Vertex Pharmaceuticals (VRTX)

$502 +0.40% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026

Reddit mentioned VRTX 7 times in the 30 days to 20 October 2026, across 3 of the communities we track. All of them were scored for sentiment: 43% read bullish, 14% bearish and 43% neither. Reddit data updated 20 October 2026.

Price · Chart
63 sessions
$600 $450 22 Jul 19 Oct

The line runs $472.73 on 22 July through $502 on 19 October, on a scale from $450 to $600. Days the market did not trade hold the previous close, flat.

Market cap $127.2B
P/E (TTM) 29.2
52-week range $406 – $558.12
Avg volume 52.9K
Mentions · 30d 7
Net sentiment +0.04

as of Oct 19, 2026

Vertex Pharmaceuticals (VRTX) · crowd attention × price

Share ↗
7 mentions

Day15 Oct 2026

MENTIONS10–3 / day
PRICE$508.93$480–$540
VRTX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day0123usd$480$500$520$54021 Sep28 Sep6 Oct13 Oct20 Oct
VRTX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.21 Sep6 Oct20 Oct
The Distributed Sentinel 20 Oct 2026

VRTX's busiest day for Reddit mentions was also its lowest close of the window — 2 mentions and $485 on 13 October

This chart in words

The chart plots daily Reddit mentions of VRTX over the 30 days to 20 October 2026: 7 in total, busiest on 13 October with 2, and 1 on the last day counted. Across this window the close ran between $485 on 13 October and $528 on 28 September. The line is the daily close over the same window: $510.64 on 21 September, $502 on 19 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Vertex Pharmaceuticals (VRTX) on Reddit · 30d

n = 7 scored · Method

In the 30 days to 21 Oct 2026, Vertex Pharmaceuticals drew 7 Reddit mentions in the finance subreddits we track, 7 of them scored for sentiment.

VRTX

43% bullish

Overall market sentiment

54% bullish

VRTX reads 11 points less bullish than overall market sentiment. Same measure; same 30-day window.

Where VRTX is discussed

(30d)
r/wallstreetbets 71% 5 +0.05
r/stocks 14% 1 +0.02
r/investing 14% 1 −0.01

Vertex Pharmaceuticals (VRTX) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Sep 2026

In the 90 days to 21 Oct 2026, no Vertex Pharmaceuticals insider bought or sold shares on the open market; all 3 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 3

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Sep 2026 van Grunsven Jasper EVP, CP and NPPO Award 8,682
28 Aug 2026 Ambrose Kristen SVP & Chief Accounting Officer Award 5,000
27 Aug 2026 SACHS BRUCE I Director Gift 6,000

Vertex Pharmaceuticals (VRTX) reported financials

SEC EDGAR XBRL SEC EDGAR

Vertex Pharmaceuticals reported revenue of $12.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $4.0B.

Figure Reported Period
Revenue $12.0B 31 Dec 2025 fiscal year
Net income $4.0B 31 Dec 2025 fiscal year
Diluted EPS $15.32 31 Dec 2025 fiscal year
Total assets $27.4B 30 Jun 2026 at period end
Total equity $20.2B 30 Jun 2026 at period end

Vertex Pharmaceuticals (VRTX) earnings

SEC EDGAR

Vertex Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $4.31; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $4.31 —
31 Mar 2026 Q1 2026 $4.02 —
31 Dec 2025 FY 2025 $15.32 —
30 Sep 2025 Q3 2025 $4.20 —
30 Jun 2025 Q2 2025 $3.99 —
31 Mar 2025 Q1 2025 $2.49 —
31 Dec 2024 FY 2024 −$2.08 —
30 Sep 2024 Q3 2024 $4.01 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Vertex Pharmaceuticals (VRTX) institutional holders (13F)

SEC Form 13F SEC EDGAR

13 of the 45 institutional funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $1.5B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +260.3% shares 616,170 $305.0M
Marshall Wace Added +71.5% shares 543,897 $270.2M
Citadel Advisors Added +50.4% shares 510,430 $253.5M
Millennium Management Added +1,419.7% shares 468,410 $232.7M
Renaissance Technologies Held (±25%) −24.1% shares 320,008 $159.0M
Two Sigma Investments Held (±25%) −24.6% shares 285,000 $141.6M
Balyasny Asset Management Added +261.3% shares 145,005 $72.0M
Man Group Trimmed −41.2% shares 139,233 $69.2M
Tudor Investment Corp New position 30,176 $15.0M
Fisher Asset Management Held (±25%) −21.4% shares 24,478 $12.2M

Showing the 10 largest of 13 reported positions. The figures above count all of them.

Vertex Pharmaceuticals (VRTX) fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 2 shares of Vertex Pharmaceuticals failed to deliver (about $1K).

Settlement date Shares failed Notional % of shares out
28 Sep 2026 2 $1K <0.001%
24 Sep 2026 24,619 $12.7M 0.010%
17 Sep 2026 126 $65K <0.001%

Congressional trades in Vertex Pharmaceuticals (VRTX)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Vertex Pharmaceuticals is a purchase by David J. Taylor (house, OH), dated 07 Aug 2025.

Date Member Type Amount
07 Aug 2025 filed 02 Sep 2025 David J. Taylor house · Republican–OH Purchase $1K–$15K
11 Jun 2025 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
10 Jun 2025 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
12 May 2025 filed 22 Jun 2025 Jefferson Shreve house · Republican–IN Sale $15K–$50K
20 Mar 2025 filed 14 Apr 2025 Byron Donalds house · Republican–FL Sale $1K–$15K
24 Feb 2025 filed 09 Mar 2025 Jefferson Shreve house · Republican–IN Purchase $15K–$50K
11 Dec 2024 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Purchase $1K–$15K
24 Oct 2023 filed 09 Nov 2023 Greg Stanton house · Democrat–AZ Sale $1K–$15K

Vertex Pharmaceuticals (VRTX): frequently asked questions

From live data

Have Vertex Pharmaceuticals insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, no Vertex Pharmaceuticals insider bought or sold shares on the open market; all 3 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

How many institutions hold Vertex Pharmaceuticals?

13 of the 45 institutional funds we track reported a Vertex Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Vertex Pharmaceuticals had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Vertex Pharmaceuticals is dated 28 Sep 2026, when 2 shares failed to deliver.

When did Vertex Pharmaceuticals last report earnings?

Vertex Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $4.31; no next date is announced in SEC filings yet.

What exchange is Vertex Pharmaceuticals listed on?

Vertex Pharmaceuticals trades on NASDAQ under the ticker VRTX.

Who is the CEO of Vertex Pharmaceuticals?

Reshma Kewalramani leads Vertex Pharmaceuticals (VRTX) as chief executive.

What is Reddit saying about Vertex Pharmaceuticals?

Vertex Pharmaceuticals was mentioned 1 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of 7 classified mentions, 43% read bullish, 14% bearish and 43% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings